Stock-Based Compensation (Tables)

6 Months Ended

Dec. 31, 2020

Stock-Based Compensation

Schedule of changes in the number of shares available for grant under equity incentive plans

	Number of Shares
Available for grant at July 1, 2020	9,519
RSUs granted	(481)
MSUs granted	(58)
Shares withheld in settlement of taxes and/or exercise price	324
Forfeitures	60
Shares removed	(84)
Available for grant at December 31, 2020	9,280

Schedule of stock-based compensation expense related to stock options, restricted stock units, market share units and the Employee Stock Purchase Plan

	Three Months Ended December 31,				Six Months Ended December 31,
	2019		2020		2019		2020
Cost of revenues	$	1,446	$	1,969	$	2,695	$	3,801
Sales and marketing		3,379		3,965		7,347		7,845
Research and development		1,768		2,738		3,046		4,968
General and administrative		6,177		7,987		11,744		14,322
Total stock-based compensation expense	$	12,770	$	16,659	$	24,832	$	30,936

Schedule of stock option activity

	Outstanding Options
				Weighted
		Weighted		average
		average		remaining	Aggregate
	Number of	exercise		contractual	intrinsic
	shares	price		term (years)	value
Balance at July 1, 2020	1,255	$	12.43	2.96	$	167,406
Options exercised	(234)	$	8.27
Balance at December 31, 2020	1,021	$	13.38	2.54	$	196,538
Options vested and exercisable at December 31, 2020	1,021	$	13.38	2.54	$	196,538

Schedule of restricted stock unit activity

	Units	Weighted average grant date fair value
RSU balance at July 1, 2020	1,626	$	73.96
RSUs granted	481	$	133.78
RSUs vested	(608)	$	64.74
RSUs forfeited	(60)	$	83.53
RSU balance at December 31, 2020	1,439	$	99.82
RSUs expected to vest at December 31, 2020	1,367	$	100.27

Summary of the assumptions used for estimating the grant date fair value of MSUs

Expected dividend yield	0	%
Expected volatility	52.0	%
Expected term (years)	3.04
Risk‑free interest rate	0.18	%